Why Robots are the Ultimate IoT Play for Retailers

 

As a Bloomberg News reporter, Josh Baylin covered technology and telecommunications policy way back at the beginning of the mobile communications revolution, leading to highly sought-after invitations to both the White House Correspondents Dinner and Congressional Internet Caucus. His investor-focused, data-driven style led to later roles as an industry analyst and investor for Legg Mason Wood Walker, Inc., and SAC Capital Advisors LP. After leaving Wall Street, he founded Velocity Growth Inc., a data and automation company focused on robotic process automation, data analytics, and visualization. Passionate about using data and automation to drive value, in 2019, Baylin joined Brain Corp.

Based in San Diego, Brain Corp is a technology company specializing in creating the world’s best AI software for building and using intelligent autonomous mobile robots (AMRs) that can support people in dynamic public spaces, such as grocery stores, retail stores, airports, hospitals, malls, universities, and more, assisting with dull, dirty, or dangerous tasks so humans have more time to do what they are uniquely qualified to do. With a concentrated focus on strategy and business development for the company, Baylin serves as Brain Corp’s Senior Director of Strategy.

On today’s Retail Refined podcast, host Melissa Gonzalez sits down with Baylin to discuss how technology innovations in retail can enhance the customer experience, including:

  • How autonomous mobile robots support retail employees while providing valuable data insights to managers, helping to optimize store operations
  • How Brain Corp’s AI solution differentiates from others
  • What BrainOS is
  • How retail workspaces are evolving, and the role robotics play in assisting employees with new day-to-day challenges
  • Brain Corp’s latest innovations around shelf scanning and how they help with store mapping, planogram planning, compliance, and pricing accuracy
  • Specific shelf scanning and delivery robot case studies, including lessons learned, outcomes and how sales were improved for those retailers
  • Surprising learnings/outcomes Baylin has seen in 2020
  • His take on the future of robotics in retail over the next 2 to 5 years
  • And more!

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More